IgAN is an autoimmune disease associated with complement activation, and extensive research has shown that hyperuricemia and the deposition of C3 are independent risk factors for IgAN progression  (Caliskan et al., 2016; Nam et al., 2020). Here, C3 is linked to hyperuricemia.